GMED - Globus Medical, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
5.28B
Enterprise Value 3
5.02B
Trailing P/E
36.90
Forward P/E 1
28.26
PEG Ratio (5 yr expected) 1
2.89
Price/Sales (ttm)
6.86
Price/Book (mrq)
3.94
Enterprise Value/Revenue 3
6.53
Enterprise Value/EBITDA 6
22.32

Trading Information

Stock Price History

Beta (5Y Monthly) 0.96
52-Week Change 321.87%
S&P500 52-Week Change 326.13%
52 Week High 360.15
52 Week Low 338.37
50-Day Moving Average 357.02
200-Day Moving Average 351.66

Share Statistics

Avg Vol (3 month) 3521.16k
Avg Vol (10 day) 3567.12k
Shares Outstanding 576.97M
Float 75.88M
% Held by Insiders 11.51%
% Held by Institutions 191.91%
Shares Short (Dec 30, 2019) 41.35M
Short Ratio (Dec 30, 2019) 43.31
Short % of Float (Dec 30, 2019) 42.05%
Short % of Shares Outstanding (Dec 30, 2019) 41.36%
Shares Short (prior month Nov 28, 2019) 41.17M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 19.03%
Operating Margin (ttm)22.66%

Management Effectiveness

Return on Assets (ttm)8.10%
Return on Equity (ttm)11.81%

Income Statement

Revenue (ttm)769.64M
Revenue Per Share (ttm)7.78
Quarterly Revenue Growth (yoy)15.90%
Gross Profit (ttm)553.56M
EBITDA 225.02M
Net Income Avi to Common (ttm)146.43M
Diluted EPS (ttm)1.44
Quarterly Earnings Growth (yoy)8.80%

Balance Sheet

Total Cash (mrq)277.49M
Total Cash Per Share (mrq)2.79
Total Debt (mrq)2.13M
Total Debt/Equity (mrq)0.16
Current Ratio (mrq)6.71
Book Value Per Share (mrq)13.47

Cash Flow Statement

Operating Cash Flow (ttm)161.96M
Levered Free Cash Flow (ttm)37.99M